435 related articles for article (PubMed ID: 22030623)
1. Dissection of cell context-dependent interactions between HBx and p53 family members in regulation of apoptosis: a role for HBV-induced HCC.
Knoll S; Fürst K; Thomas S; Villanueva Baselga S; Stoll A; Schaefer S; Pützer BM
Cell Cycle; 2011 Oct; 10(20):3554-65. PubMed ID: 22030623
[TBL] [Abstract][Full Text] [Related]
2. Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways.
Arbuthnot P; Capovilla A; Kew M
J Gastroenterol Hepatol; 2000 Apr; 15(4):357-68. PubMed ID: 10824878
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus X promotes hepatocellular carcinoma development via nuclear protein 1 pathway.
Bak Y; Shin HJ; Bak Is; Yoon DY; Yu DY
Biochem Biophys Res Commun; 2015 Oct; 466(4):676-81. PubMed ID: 26392315
[TBL] [Abstract][Full Text] [Related]
4. Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma.
Nieto-Rementería N; Pérez-Yarza G; Boyano MD; Apraiz A; Izu R; Díaz-Pérez JL; Asumendi A
Br J Dermatol; 2009 Mar; 160(3):519-26. PubMed ID: 19067706
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis.
Huo TI; Wang XW; Forgues M; Wu CG; Spillare EA; Giannini C; Brechot C; Harris CC
Oncogene; 2001 Jun; 20(28):3620-8. PubMed ID: 11439325
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic circuit constituted by Ser31-HBx and Akt increases risks of chronic hepatitis and hepatocellular carcinoma.
Lee WP; Lan KH; Li CP; Chao Y; Lin HC; Lee SD
Biochim Biophys Acta; 2016 Apr; 1862(4):837-849. PubMed ID: 26791804
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus X protein activates E3 ubiquitin ligase Siah-1 to control virus propagation via a negative feedback loop.
Yeom S; Kim SS; Jeong H; Jang KL
J Gen Virol; 2017 Jul; 98(7):1774-1784. PubMed ID: 28714848
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of p73-mediated regulation of hepatitis B virus core promoter/enhancer II: implications for hepatocarcinogenesis.
Buhlmann S; Racek T; Schwarz A; Schaefer S; Pützer BM
J Mol Biol; 2008 Apr; 378(1):20-30. PubMed ID: 18342333
[TBL] [Abstract][Full Text] [Related]
9. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
10. Polo-like kinase 1 inhibition suppresses hepatitis B virus X protein-induced transformation in an in vitro model of liver cancer progression.
Studach LL; Rakotomalala L; Wang WH; Hullinger RL; Cairo S; Buendia MA; Andrisani OM
Hepatology; 2009 Aug; 50(2):414-23. PubMed ID: 19472310
[TBL] [Abstract][Full Text] [Related]
11. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
[TBL] [Abstract][Full Text] [Related]
12. Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis.
Zhu R; Mok MT; Kang W; Lau SS; Yip WK; Chen Y; Lai PB; Wong VW; To KF; Sung JJ; Cheng AS; Chan HL
J Pathol; 2015 Sep; 237(1):38-49. PubMed ID: 25925944
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-602 regulating tumor suppressive gene RASSF1A is overexpressed in hepatitis B virus-infected liver and hepatocellular carcinoma.
Yang L; Ma Z; Wang D; Zhao W; Chen L; Wang G
Cancer Biol Ther; 2010 May; 9(10):803-8. PubMed ID: 20364114
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K
Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of hepatitis-B-virus core promoter by p53: implications for carcinogenesis in hepatocytes.
Uchida T; Takahashi K; Tatsuno K; Dhingra U; Eliason JF
Int J Cancer; 1996 Sep; 67(6):892-7. PubMed ID: 8824564
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells.
Zhang T; Zhang J; You X; Liu Q; Du Y; Gao Y; Shan C; Kong G; Wang Y; Yang X; Ye L; Zhang X
Hepatology; 2012 Dec; 56(6):2051-9. PubMed ID: 22707013
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus X protein represses LKB1 expression to promote tumor progression and poor postoperative outcome in hepatocellular carcinoma.
Wu CC; Wu DW; Lin YY; Lin PL; Lee H
Surgery; 2018 May; 163(5):1040-1046. PubMed ID: 29475611
[TBL] [Abstract][Full Text] [Related]
18. HBV suppresses ZHX2 expression to promote proliferation of HCC through miR-155 activation.
Song X; Tan S; Wu Z; Xu L; Wang Z; Xu Y; Wang T; Gao C; Gong Y; Liang X; Gao L; Spear BT; Ma C
Int J Cancer; 2018 Dec; 143(12):3120-3130. PubMed ID: 29752719
[TBL] [Abstract][Full Text] [Related]
19. Altered binding site selection of p53 transcription cassettes by hepatitis B virus X protein.
Chan C; Wang Y; Chow PK; Chung AY; Ooi LL; Lee CG
Mol Cell Biol; 2013 Feb; 33(3):485-97. PubMed ID: 23149944
[TBL] [Abstract][Full Text] [Related]
20. COX-2 mediates hepatitis B virus X protein abrogation of p53-induced apoptosis.
Cheng AS; Yu J; Lai PB; Chan HL; Sung JJ
Biochem Biophys Res Commun; 2008 Sep; 374(2):175-80. PubMed ID: 18601905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
